Paper356311
Tranexamic acid in the preoperative management of ruptured intracranial aneurysms.
Fodstad H and 3 others. Surg Neurol, 1978. Cited by 71 papers, by iCite.
Cite this record
ConductScience Library. Tranexamic acid in the preoperative management of ruptured intracranial aneurysms. Papers, record 356311. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/356311
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics17
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Cyclohexanecarboxylic Acids | Major topic |
| Intracranial Aneurysm | Major topic |
| Tranexamic Acid | Major topic |
| Adult | |
| Aged | |
| Antifibrinolytic Agents | |
| Clinical Trials as Topic | |
| Constriction, Pathologic | |
| Female | |
| Humans | |
| Hydrocephalus | |
| Male | |
| Middle Aged | |
| Postoperative Complications | |
| Recurrence | |
| Rupture, Spontaneous | |
| Subarachnoid Hemorrhage |
Source PubMed
Cited by26
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 71 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 36350005 | Antifibrinolytic therapy for aneurysmal subarachnoid haemorrhage. | Cochrane Database Syst Rev | 2022 | https://conductscience.org/library/papers/36350005 | PubMed |
| 35140671 | Safety and Efficacy of Tranexamic Acid in Aneurysmal Subarachnoid Hemorrhage: A Meta-Analysis of Randomized Controlled Trials. | Front Neurol | 2021 | https://conductscience.org/library/papers/35140671 | PubMed |
| 35083272 | Efficacy and Safety of Tranexamic Acid in Aneurysmal Subarachnoid Hemorrhage: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. | Front Surg | 2021 | https://conductscience.org/library/papers/35083272 | PubMed |
| 34315966 | Tranexamic acid in non-traumatic intracranial bleeding: a systematic review and meta-analysis. | Sci Rep | 2021 | https://conductscience.org/library/papers/34315966 | PubMed |
| 33851983 | Association of Intravenous Tranexamic Acid With Thromboembolic Events and Mortality: A Systematic Review, Meta-analysis, and Meta-regression. | JAMA Surg | 2021 | https://conductscience.org/library/papers/33851983 | PubMed |
| 33222913 | Subarachnoid hemorrhage rebleeding in the first 24 h is associated with external ventricular drain placement and higher grade on presentation: Cohort study. | J Clin Neurosci | 2020 | https://conductscience.org/library/papers/33222913 | PubMed |
| 23990381 | Antifibrinolytic therapy for aneurysmal subarachnoid haemorrhage. | Cochrane Database Syst Rev | 2013 | https://conductscience.org/library/papers/23990381 | PubMed |
| 18386187 | Antifibrinolytic therapy to prevent early rebleeding after subarachnoid hemorrhage. | Neurocrit Care | 2008 | https://conductscience.org/library/papers/18386187 | PubMed |
| 10400410 | Tranexamic acid: a review of its use in surgery and other indications. | Drugs | 1999 | https://conductscience.org/library/papers/10400410 | PubMed |
| 7435291 | Effect of antifibrinolytic therapy on subarachnoid fibrosis in dogs after experimental subarachnoid haemorrhage. | Acta Neurochir (Wien) | 1980 | https://conductscience.org/library/papers/7435291 | PubMed |
| 7435290 | Letter to the editors of acta neurochirurgica. Management of patients with subarachnoid haemorrhage with tranexamic acid. | Acta Neurochir (Wien) | 1980 | https://conductscience.org/library/papers/7435290 | PubMed |
| 7359154 | Monitoring fibrinolytic activity in the cerebrospinal fluid after aneurysmal subarachnoid haemorrhage: a guide to the risk of rebleeding? | J Neurol Neurosurg Psychiatry | 1980 | https://conductscience.org/library/papers/7359154 | PubMed |
| 7282453 | Determination of tranexamic acid (AMCA) and fibrin/fibrinogen degradation products in cerebrospinal fluid after aneurysmal subarachnoid haemorrhage. | Acta Neurochir (Wien) | 1981 | https://conductscience.org/library/papers/7282453 | PubMed |
| 7102384 | Double-blind trial of aspirin in patient receiving tranexamic acid for subarachnoid hemorrhage. | Acta Neurochir (Wien) | 1982 | https://conductscience.org/library/papers/7102384 | PubMed |
| 7048863 | Antifibrinolytic treatment in subarachnoid haemorrhage: present state. | Acta Neurochir (Wien) | 1982 | https://conductscience.org/library/papers/7048863 | PubMed |
| 7031186 | Comparative clinical trial of epsilon amino-caproic acid and tranexamic acid in the prevention of early recurrence of subarachnoid haemorrhage. | J Neurol Neurosurg Psychiatry | 1981 | https://conductscience.org/library/papers/7031186 | PubMed |
| 7000850 | Tranexamic acid (AMCA) in aneurysmal subarachnoid haemorrhage. | J Clin Pathol Suppl (R Coll Pathol) | 1980 | https://conductscience.org/library/papers/7000850 | PubMed |
| 6741629 | Retrospective analysis of 162 consecutive cases of ruptured intracranial aneurysms. Total mortality and early surgery. | Acta Neurochir (Wien) | 1984 | https://conductscience.org/library/papers/6741629 | PubMed |
| 6179402 | Antifibrinolytics in aneurysmal subarachnoid haemorrhage. A retrospective comparison of two different forms of antifibrinolytic therapy. | Acta Neurochir (Wien) | 1982 | https://conductscience.org/library/papers/6179402 | PubMed |
| 3546604 | Antifibrinolytic agents in subarachnoid haemorrhage. | J Neurol | 1987 | https://conductscience.org/library/papers/3546604 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/356311
GET https://conductscience.org/api/papers/v1/356311/cited_by?page=2